— Know what they know.
Not Investment Advice

NUMD OTC

Nu-Med Plus, Inc.
1W: -36.5% 1M: -40.2% 3M: +33.3% YTD: +2.8% 1Y: -53.2% 3Y: -36.5% 5Y: -88.8%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 33 · $1.2M mcap · 46M float · 0.036% daily turnover · Short 53% of daily vol

Balance Sheet Trends

Total Assets
$9K -30.3% ▼
5Y CAGR: -27.2%
Total Liabilities
$224K +40.1% ▲
5Y CAGR: -11.6%
Shareholders Equity
-$215K -46.6% ▼
Cash & Investments
$2K -65.1% ▼
5Y CAGR: -19.6%
Total Debt
$100K +0.0% ▲
5Y CAGR: -16.0%
Net Debt
$98K +4.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$189K$12K$73K$7K$2K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$189K$12K$73K$7K$2K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$538K$12K$80K$13K$9K
Property, Plant & Equip.$20K$10K$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$0$0-$2M-$2M-$2M
Total Non-Current Assets$20K$10K-$1K$0$0
Total Assets$557K$22K$80K$13K$9K
— Liabilities —
Accounts Payable$46K$54K$42K$54K$43K
Short-Term Debt$8K$8K$100K$100K$100K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities-$8K-$8K$0$0$67K
Total Current Liabilities$80K$155K$143K$160K$224K
Long-Term Debt$9K$0$0$0$0
Other Non-Current Liab.$0$0-$2M-$2M$0
Total Non-Current Liabilities$9K$0$7K$0$2M
Total Liabilities$89K$155K$143K$160K$224K
— Equity —
Common Stock$51K$79K$81K$84K$84K
Retained Earnings-$9M-$10M-$10M-$10M-$10M
Accumulated OCI$724K-$0$0$0$0
Total Stockholders Equity$468K-$132K-$63K-$147K-$215K
Total Liabilities & Equity$557K$22K$80K$13K$9K
— Key Metrics —
Total Debt$17K$8K$100K$100K$100K
Net Debt-$171K-$3K$27K$93K$98K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms